| MeSH term | MeSH ID | Detail |
|---|---|---|
| Lymphoma, Large-Cell, Anaplastic | D017728 | 3 associated lipids |
| Fibromatosis, Aggressive | D018222 | 2 associated lipids |
| Rhabdomyosarcoma, Alveolar | D018232 | 2 associated lipids |
| Rhabdomyosarcoma, Embryonal | D018233 | 1 associated lipids |
| Carcinoma, Embryonal | D018236 | 8 associated lipids |
| Adenocarcinoma, Follicular | D018263 | 3 associated lipids |
| Carcinoma, Papillary, Follicular | D018265 | 1 associated lipids |
| Carcinoma, Ductal, Breast | D018270 | 19 associated lipids |
| Cystadenocarcinoma, Mucinous | D018282 | 1 associated lipids |
| Cystadenocarcinoma, Serous | D018284 | 2 associated lipids |
trichostatin A
Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.
Cross Reference
Introduction
To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with trichostatin A?
trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with trichostatin A
PubChem Associated disorders and diseases
What pathways are associated with trichostatin A
Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with trichostatin A?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with trichostatin A?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with trichostatin A?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with trichostatin A?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with trichostatin A?
Mouse Model
Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).
Xenograft Model
Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).
Cancer Model
Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with trichostatin A
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Peng L et al. | Epigenetic inactivation of ADAMTS9 via promoter methylation in multiple myeloma. | 2013 | Mol Med Rep | pmid:23358566 |
| Corvetta D et al. | Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: functional and therapeutic implications. | 2013 | J. Biol. Chem. | pmid:23362253 |
| Dhawan D et al. | DNMT1: an emerging target in the treatment of invasive urinary bladder cancer. | 2013 | Urol. Oncol. | pmid:22609058 |
| Oikawa M et al. | RNAi-mediated knockdown of Xist does not rescue the impaired development of female cloned mouse embryos. | 2013 | J. Reprod. Dev. | pmid:23363561 |
| Dagnas M et al. | HDAC inhibition facilitates the switch between memory systems in young but not aged mice. | 2013 | J. Neurosci. | pmid:23365234 |
| Fernandez G et al. | Targeting IκB proteins for HIV latency activation: the role of individual IκB and NF-κB proteins. | 2013 | J. Virol. | pmid:23365428 |
| Meng F et al. | Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer. | 2013 | Br. J. Cancer | pmid:23370212 |
| Wang Z et al. | Arabidopsis paired amphipathic helix proteins SNL1 and SNL2 redundantly regulate primary seed dormancy via abscisic acid-ethylene antagonism mediated by histone deacetylation. | 2013 | Plant Cell | pmid:23371947 |
| Seuter S et al. | Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression. | 2013 | Nucleic Acids Res. | pmid:23093607 |
| Jin H et al. | HDAC inhibitor trichostatin A promotes proliferation and odontoblast differentiation of human dental pulp stem cells. | 2013 | Tissue Eng Part A | pmid:23013422 |
| Mateen S et al. | Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells. | 2013 | J. Pharmacol. Exp. Ther. | pmid:23461975 |
| Chambliss AB et al. | Simultaneously defining cell phenotypes, cell cycle, and chromatin modifications at single-cell resolution. | 2013 | FASEB J. | pmid:23538711 |
| Wang YG et al. | Mechanisms of trichostatin A inhibiting AGS proliferation and identification of lysine-acetylated proteins. | 2013 | World J. Gastroenterol. | pmid:23745024 |
| Guo SW et al. | Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis. | 2013 | Fertil. Steril. | pmid:22999795 |
| Pitta CA et al. | Reversal of ER-β silencing by chromatin modifying agents overrides acquired tamoxifen resistance. | 2013 | Cancer Lett. | pmid:23752064 |
| Zhang C et al. | Decreased PADI4 mRNA association with global hypomethylation in hepatocellular carcinoma during HBV exposure. | 2013 | Cell Biochem. Biophys. | pmid:22907585 |
| Van Beneden K et al. | Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis. | 2013 | Toxicol. Appl. Pharmacol. | pmid:23707763 |
| Meng F et al. | Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3. | 2013 | Int. J. Oncol. | pmid:23709006 |
| Liu Y et al. | MCM-2 is a therapeutic target of Trichostatin A in colon cancer cells. | 2013 | Toxicol. Lett. | pmid:23770000 |
| Spallotta F et al. | A nitric oxide-dependent cross-talk between class I and III histone deacetylases accelerates skin repair. | 2013 | J. Biol. Chem. | pmid:23463510 |
| Chandwani S et al. | Induction of DARPP-32 by brain-derived neurotrophic factor in striatal neurons in vitro is modified by histone deacetylase inhibitors and Nab2. | 2013 | PLoS ONE | pmid:24204683 |
| Liesz A et al. | Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. | 2013 | J. Neurosci. | pmid:24174668 |
| Wu DS et al. | Epigallocatechin-3-gallate and trichostatin A synergistically inhibit human lymphoma cell proliferation through epigenetic modification of p16INK4a. | 2013 | Oncol. Rep. | pmid:24064951 |
| Al-Nakhle H et al. | Regulation of estrogen receptor β1 expression in breast cancer by epigenetic modification of the 5' regulatory region. | 2013 | Int. J. Oncol. | pmid:24068253 |
| Fujiki R et al. | A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons. | 2013 | Cell Death Dis | pmid:23788034 |
| Chang X et al. | DNA methylation of NDRG2 in gastric cancer and its clinical significance. | 2013 | Dig. Dis. Sci. | pmid:23010743 |
| Li KK et al. | MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3). | 2013 | Brain Pathol. | pmid:23227829 |
| Matsubara K et al. | Dynamics and regulation of lysine-acetylation during one-cell stage mouse embryos. | 2013 | Biochem. Biophys. Res. Commun. | pmid:23567968 |
| Duo J et al. | Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line. | 2013 | DNA Cell Biol. | pmid:23451817 |
| Chen CQ et al. | Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases. | 2013 | Carcinogenesis | pmid:23430957 |
| Han B et al. | Trichostatin A stabilizes the expression of pluripotent genes in human mesenchymal stem cells during ex vivo expansion. | 2013 | PLoS ONE | pmid:24312356 |
| Katsuno M et al. | [Dysfunction of dynactin 1 in motor neuron degeneration]. | 2013 | Rinsho Shinkeigaku | pmid:24291886 |
| Wang X et al. | Combined histone deacetylase and cyclooxygenase inhibition achieves enhanced antiangiogenic effects in lung cancer cells. | 2013 | Mol. Carcinog. | pmid:22121107 |
| Wang P et al. | Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function. | 2013 | Neurotoxicology | pmid:23558232 |
| Lee AR et al. | Nicotinamide: a class III HDACi delays in vitro aging of mouse oocytes. | 2013 | J. Reprod. Dev. | pmid:23474603 |
| Chatterjee N et al. | Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cells. | 2013 | Cancer Biol. Ther. | pmid:23792638 |
| Zych J et al. | The epigenetic modifiers 5-aza-2'-deoxycytidine and trichostatin A influence adipocyte differentiation in human mesenchymal stem cells. | 2013 | Braz. J. Med. Biol. Res. | pmid:23797495 |
| Guo LH et al. | The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer. | 2013 | Int J Mol Sci | pmid:23880861 |
| Jo SJ et al. | Valproic acid promotes human hair growth in in vitro culture model. | 2013 | J. Dermatol. Sci. | pmid:23810771 |
| Huang L et al. | Down-regulation of miR-301a suppresses pro-inflammatory cytokines in Toll-like receptor-triggered macrophages. | 2013 | Immunology | pmid:23808420 |
| Keuser B et al. | Influences of histone deacetylase inhibitors and resveratrol on DNA repair and chromatin compaction. | 2013 | Mutagenesis | pmid:23814181 |
| Lim SY et al. | Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering. | 2013 | Stem Cells Transl Med | pmid:23884641 |
| Shim SH et al. | Histone deacetylase inhibitors suppress coxsackievirus B3 growth in vitro and myocarditis induced in mice. | 2013 | Acta Virol. | pmid:24294962 |
| Kamiya H et al. | Enhanced transgene expression from chromatinized plasmid DNA in mouse liver. | 2013 | Int J Pharm | pmid:23247018 |
| Yang L et al. | Trichostatin A inhibits transforming growth factor-β-induced reactive oxygen species accumulation and myofibroblast differentiation via enhanced NF-E2-related factor 2-antioxidant response element signaling. | 2013 | Mol. Pharmacol. | pmid:23284002 |
| Zhang S et al. | Effect of trichostatin A and paclitaxel on the proliferation and apoptosis of lung adenocarcinoma cells. | 2013 | Chin. Med. J. | pmid:23286491 |
| Gao C et al. | Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex. | 2013 | Blood | pmid:23287862 |
| Marek L et al. | Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells. | 2013 | J. Med. Chem. | pmid:23252603 |
| Li KK et al. | MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L. | 2013 | Brain Pathol. | pmid:23252729 |
| Chen CQ et al. | Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer. | 2013 | Mol. Cell. Biochem. | pmid:23867991 |